US Tariffs And The EU’s Critical Medicines Act: Lessons On Nearshoring And CMO Diversification

 
• By Francesca Bruce
  
Companies can prepare for measures in different markets that encourage domestic production by evaluating their manufacturing strategies. (Shutterstock)

More from Compliance

More from United States